膀胱癌染色体及基因FISH检测试剂盒
| 型 号： | |
| 报 价： |  |
膀胱癌染色体及基因FISH检测试剂盒 膀胱癌的病因复杂，既有内在的遗传因素，又有外在的环境因素。较为明确的两大致病危险因素是吸烟和职业接触芳香胺类化学物质。吸烟是目前Z为肯定的膀胱癌致病危险因素，30%～50%的膀胱癌由吸烟引起，吸烟可使膀胱癌危险率增加2～6倍，随着吸烟时间的延长，膀胱癌的发病率也明显增高。另一重要的致病危险因素是与一系列职业或职业接触有关。
- 产品描述
膀胱癌染色体及基因FISH检测试剂盒
广州健仑生物科技?有限公司
本司长期供应尼古丁（可替宁）检测试剂盒，其主要品牌包括美国NovaBios、广州健仑、广州创仑等进口产品，国产产品，试剂盒的实验方法是胶体金方法。
我司还有很多荧光原位杂交系列检测试剂盒以及各种FISH基因探针和染色体探针等，。
人类该基因定位于染色体17q12，其编码产物为185kD的跨膜精蛋白p185，由1255个氨基酸组成，720—987位属于酪氨酸激酶区。Her-2/neu蛋白是具有酪氨酸蛋白激酶活性跨膜糖蛋白，是EGFR家族成员之一。
欢迎咨询
欢迎咨询
以下是我司出售的部分FISH产品：
| D13S25（13q14）探针（红色） |
| JAK2（9p24）基因断裂探针 |
| FRS2（12q15）基因探针 |
| p53/RB1/ATM/CSP12/D13S25/6/6q21/IGH基因探针(七探针 ) |
| MYC（8q24），BCL6（3q37），BCL2（18q21）探针 |
| API2/MALT1融合基因t(11;18)探针 |
| MALT1/IGH融合基因t(14;18)探针 |
| IGH融合基因（CCND1,MAF,MAFB,FGFR3）探针 |
| ALK、MET、ROS1基因探针 |
| FGFR1,PDGFRA,PDGFRB基因探针 |
| 7号/8号染色体探针 |
| 8号/17号染色体探针 |
| 8号染色体计数探针（红色） |
| D7S522（7q31）基因探针 |
| RB1(13q14)/ATM(11q22)基因探针 |
| 12/D13S25基因探针 |
| p53/D13S319基因探针 |
| RB1/1q21基因探针 |
| 5q31(EGR1)基因探针 |
| BCL2（18q21）基因断裂探针 |
| BCL6/IGH融合基因 t(3; 14) 探针 |
| KMT2A/AFF1融合基因t(4; 11) 探针 |
膀胱癌染色体及基因FISH检测试剂盒我司还提供：登革热，黄热病，基肯孔热，西尼罗河，立次克体，无形体，蜱虫，恙虫，锥虫，利什曼原虫，RK39, 汉坦病毒，乙脑，森林脑炎，寨卡病毒 ，H7N9 ,流感，霍乱，军团菌，结核，诺如病毒，轮状病毒，炭疽，O157，葡萄球菌 ，流行性出血热，伤寒杆菌，志贺氏菌检测试剂,！
二维码扫一扫
【公司名称】 广州健仑生物科技有限公司
【】 杨永汉
【】
【腾讯 】
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-3室
【企业文化宣传】
About 90% of patients with bladder cancer are initially diagnosed with hematuria. They are usually painless, intermittent, gross hematuria and sometimes hematuria. Hematuria may be only 1 or 1 days to several days, can be reduced or stopped, sometimes patients with hematuria often stop coincidence to patients was "illusion. Some patients may have hematuria again after a few periods of time apart. Blood urine stain from light red to dark brown, often dark red, the patient described it as washing water samples, tea water samples. The length of the amount of bleeding and the duration of hematuria is not necessarily proportional to the malignancy, size, range, and number of the tumor. Sometimes the tumor is very large or late in the hematuria, and sometimes a small tumor has a large amount of hematuria. Some patients found a tumor in the bladder when they were examined by B ultrasound during physical examination. 10% of the patients with bladder cancer can be the first symptoms of bladder stimulation, characterized by frequent urination and dysuria, urgency, dysuria, and patients without obvious hematuria. This is mostly due to tumor necrosis, ulceration, large or large number of bladder tumors, or diffuse bladder tumor infiltrating the bladder wall, resulting in decreased bladder volume or concurrent infection. The tumor of the bladder triangle and the neck of the bladder can obstruct the exportation of the bladder, with symptoms of difficulty in urination.
